Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Prothrombin Complex Market by Type (500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others), By Application (Hemophilia B, Vitamin K Deficiency, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Prothrombin Complex Market by Type (500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others), By Application (Hemophilia B, Vitamin K Deficiency, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 208806 3300 Pharma & Healthcare 377 241 Pages 4.9 (35)
                                          

The global prothrombin complex market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of hemophilia B and vitamin K deficiency, growing awareness about prothrombin complex therapy among physicians and patients, and technological advancements in the field of hemostasis. The global prothrombin complex market is segmented on the basis of type (500 IU/vial, 600 IU/vial, 1000 IU/vial), application (hemophilia B, vitamin K deficiency) and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). North America accounted for the largest share in the global prothrombin complex market in 2018 owing to high prevalence rates of hemophilia B and vitamin K deficiency in this region. The European region accounted for a significant share due to high awareness about prothrombin complex therapy among physicians as well as patients.

Some Of The Growth Factors Of This Market:

  1. Increasing awareness about the benefits of prothrombin complex therapy among physicians and patients will also drive growth in this market during the forecast period (2017-2025).
  2. The high cost associated with prothrombin complex therapy is expected to restrain growth in this market during the forecast period (2017-2025) 5) Increasing number of clinical trials on prothrombin complexes will provide opportunities for manufacturers.

Industry Growth Insights published a new data on “Prothrombin Complex Market”. The research report is titled “Prothrombin Complex Market research by Types (500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others), By Applications (Hemophilia B, Vitamin K Deficiency, Others), By Players/Companies Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Prothrombin Complex Market Research Report

By Type

500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others

By Application

Hemophilia B, Vitamin K Deficiency, Others

By Companies

Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Prothrombin Complex Industry Outlook


Global Prothrombin Complex Market Report Segments:

The global Prothrombin Complex market is segmented on the basis of:

Types

500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hemophilia B, Vitamin K Deficiency, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Shire
  2. CSL
  3. Grifols
  4. Octapharma
  5. Hualan Biological
  6. Meheco Xinxing Pharma

Global Prothrombin Complex Market Overview


Highlights of The Prothrombin Complex Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 500 IU/Vial
    2. 600 IU/Vial
    3. 1000 IU/Vial
    4. Others
  1. By Application:

    1. Hemophilia B
    2. Vitamin K Deficiency
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Prothrombin Complex Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Prothrombin Complex Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Prothrombin complex is a protein that helps to form thrombin. Thrombin is a protein that helps to break down blood clots.

Some of the key players operating in the prothrombin complex market are Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma.

The prothrombin complex market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Prothrombin Complex Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Prothrombin Complex Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Prothrombin Complex Market - Supply Chain
   4.5. Global Prothrombin Complex Market Forecast
      4.5.1. Prothrombin Complex Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Prothrombin Complex Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Prothrombin Complex Market Absolute $ Opportunity

5. Global Prothrombin Complex Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Prothrombin Complex Market Size and Volume Forecast by Type
      5.3.1. 500 IU/Vial
      5.3.2. 600 IU/Vial
      5.3.3. 1000 IU/Vial
      5.3.4. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Prothrombin Complex Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Prothrombin Complex Market Size and Volume Forecast by Application
      6.3.1. Hemophilia B
      6.3.2. Vitamin K Deficiency
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Prothrombin Complex Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Prothrombin Complex Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Prothrombin Complex Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Prothrombin Complex Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Prothrombin Complex Demand Share Forecast, 2019-2026

9. North America Prothrombin Complex Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Prothrombin Complex Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Prothrombin Complex Market Size and Volume Forecast by Application
      9.4.1. Hemophilia B
      9.4.2. Vitamin K Deficiency
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Prothrombin Complex Market Size and Volume Forecast by Type
      9.7.1. 500 IU/Vial
      9.7.2. 600 IU/Vial
      9.7.3. 1000 IU/Vial
      9.7.4. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Prothrombin Complex Demand Share Forecast, 2019-2026

10. Latin America Prothrombin Complex Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Prothrombin Complex Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Prothrombin Complex Market Size and Volume Forecast by Application
      10.4.1. Hemophilia B
      10.4.2. Vitamin K Deficiency
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Prothrombin Complex Market Size and Volume Forecast by Type
      10.7.1. 500 IU/Vial
      10.7.2. 600 IU/Vial
      10.7.3. 1000 IU/Vial
      10.7.4. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Prothrombin Complex Demand Share Forecast, 2019-2026

11. Europe Prothrombin Complex Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Prothrombin Complex Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Prothrombin Complex Market Size and Volume Forecast by Application
      11.4.1. Hemophilia B
      11.4.2. Vitamin K Deficiency
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Prothrombin Complex Market Size and Volume Forecast by Type
      11.7.1. 500 IU/Vial
      11.7.2. 600 IU/Vial
      11.7.3. 1000 IU/Vial
      11.7.4. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Prothrombin Complex Demand Share, 2019-2026

12. Asia Pacific Prothrombin Complex Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Prothrombin Complex Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Prothrombin Complex Market Size and Volume Forecast by Application
      12.4.1. Hemophilia B
      12.4.2. Vitamin K Deficiency
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Prothrombin Complex Market Size and Volume Forecast by Type
      12.7.1. 500 IU/Vial
      12.7.2. 600 IU/Vial
      12.7.3. 1000 IU/Vial
      12.7.4. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Prothrombin Complex Demand Share, 2019-2026

13. Middle East & Africa Prothrombin Complex Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Prothrombin Complex Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Prothrombin Complex Market Size and Volume Forecast by Application
      13.4.1. Hemophilia B
      13.4.2. Vitamin K Deficiency
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Prothrombin Complex Market Size and Volume Forecast by Type
      13.7.1. 500 IU/Vial
      13.7.2. 600 IU/Vial
      13.7.3. 1000 IU/Vial
      13.7.4. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Prothrombin Complex Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Prothrombin Complex Market: Market Share Analysis
   14.2. Prothrombin Complex Distributors and Customers
   14.3. Prothrombin Complex Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Shire
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. CSL
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Grifols
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Octapharma
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Hualan Biological
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Meheco Xinxing Pharma
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us